Top compounds associated with response to GLP2R


Feature Type Standardized
Nominal ANOVA
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.06 0.09
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.09
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.054 0.09
mRNA thapsigargin gCSI pan-cancer AAC 0.11 0.09
mRNA salermide CTRPv2 pan-cancer AAC -0.077 0.09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.09
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.056 0.09
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.06 0.09
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.05 0.09
mRNA Topotecan CCLE pan-cancer AAC -0.071 0.09
Download CSV